Plus   Neg

Heineken Shareholders Adopt All Proposals

Dutch brewer Heineken NV (HKHHF.PK) said that its Annual General Meeting of Shareholders has adopted all proposals on the agenda of the AGM.

The AGM approved the appointment of Dolf van den Brink as member of the Executive Board of HEINEKEN for a period of four years. Dolf van den Brink will become Chairman of the Executive Board and CEO of HEINEKEN on 1 June 2020.

Jean-François van Boxmeer will step down as Chairman of the Executive Board and CEO of HEINEKEN. He will hand over his responsibilities to Dolf van den Brink on 1 June 2020.

The AGM approved the dividend proposal for the year 2019 of 1.68 euros per share. As an interim dividend of EUR 0.64 was paid on 8 August 2019, the final dividend will be 1.04 euros per share. The final dividend will be made payable on 7 May 2020.

The AGM resolved to adjust the remuneration policy for the Executive Board and adopt a remuneration policy for the Supervisory Board.

The AGM re-appointed Pamela Mars Wright as member of the Supervisory Board for a four-year term.

The AGM re-appointed Deloitte Accountants B.V. as external auditor for the financial year 2021.

The AGM adopted amendments to the articles of association to align with current statutory Dutch law and make textual improvements.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Facebook has unveiled Instagram Reels as its answer to the popular Chinese-owned video app TikTok. The social media giant said in a blog post that Instagram Reels is a new way to create short, entertaining videos on Facebook's photo-sharing app Instagram. Facebook reportedly shut down its TikTok clone Lasso in July, ahead of the launch of Instagram Reels. WD-40 Company recalled about 130,000 units of X-14 Mildew Stain Remover for potential risk of skin irritation, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said pressure can build up inside the bottle and cause it to fall over and leak, posing a risk of skin irritation. Biopharmaceutical company Bristol-Myers Squibb Co. on Thursday reported a loss for the second quarter, compared to a profit last year, hurt primarily by hefty amortization expenses. However, adjusted earnings per share and quarterly revenues topped analysts' expectations. Looking ahead, the company raised its adjusted earnings and revenue outlook for the full-year 2020.
Follow RTT